Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Jenkins

Showing results (81-90 of 269) with videos related to

Pageof 27
Sort By:
Plos One|October 11, 2008
A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapyTohru Nakagawa, Thomas M Kollmeyer, Bruce W Morlan, et al.
Genes, Chromosomes & Cancer|July 6, 2004
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriersCamilo Adem, Cheryl L Soderberg, Kari Hafner, et al.
International Journal of Oncology|September 30, 2010
Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenograftsAntonino B D'Assoro, Alexey Leontovich, Angela Amato, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 16, 2016
PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillanceBruce J Trock, Helen Fedor, Bora Gurel, et al.
Neuro-Oncology Practice|July 21, 2022
Inherited genetics of adult diffuse glioma and polygenic risk scores-a reviewJeanette E Eckel-Passow, Daniel H Lachance, Paul A Decker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2012
Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinomaHarry H Yoon, Qian Shi, William R Sukov, et al.
Nature Genetics|June 23, 2004
BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in miceDarren J Baker, Karthik B Jeganathan, J Douglas Cameron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2012
Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomasHarry H Yoon, Qian Shi, William R Sukov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastomaChristopher E Pelloski, Anita Mahajan, Moshe Maor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists GuidelinesMithun Vinod Shah, Anne E Wiktor, Reid G Meyer, et al.
Pageof 27

Showing results (81-90 of 269) with videos related to

Sort By:
Pageof 27
Plos One|October 11, 2008
A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapyTohru Nakagawa, Thomas M Kollmeyer, Bruce W Morlan, et al.
Genes, Chromosomes & Cancer|July 6, 2004
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriersCamilo Adem, Cheryl L Soderberg, Kari Hafner, et al.
International Journal of Oncology|September 30, 2010
Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenograftsAntonino B D'Assoro, Alexey Leontovich, Angela Amato, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 16, 2016
PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillanceBruce J Trock, Helen Fedor, Bora Gurel, et al.
Neuro-Oncology Practice|July 21, 2022
Inherited genetics of adult diffuse glioma and polygenic risk scores-a reviewJeanette E Eckel-Passow, Daniel H Lachance, Paul A Decker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2012
Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinomaHarry H Yoon, Qian Shi, William R Sukov, et al.
Nature Genetics|June 23, 2004
BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in miceDarren J Baker, Karthik B Jeganathan, J Douglas Cameron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2012
Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomasHarry H Yoon, Qian Shi, William R Sukov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastomaChristopher E Pelloski, Anita Mahajan, Moshe Maor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists GuidelinesMithun Vinod Shah, Anne E Wiktor, Reid G Meyer, et al.
Pageof 27